Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Daiichi Sankyo
McKesson
Chinese Patent Office
UBS
QuintilesIMS
Healthtrust
Federal Trade Commission
Colorcon

Generated: February 19, 2018

DrugPatentWatch Database Preview

ZINACEF Drug Profile

« Back to Dashboard

Which patents cover Zinacef, and what generic alternatives are available?

Zinacef is a drug marketed by Teligent and is included in two NDAs.

The generic ingredient in ZINACEF is cefuroxime sodium. There are sixty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.

US Patents and Regulatory Information for ZINACEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent ZINACEF cefuroxime sodium INJECTABLE;INJECTION 050558-003 Oct 19, 1983 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent ZINACEF IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 050643-001 Apr 28, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent ZINACEF cefuroxime sodium INJECTABLE;INJECTION 050558-004 Oct 23, 1986 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent ZINACEF cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 050558-002 Oct 19, 1983 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent ZINACEF IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 050643-002 Apr 28, 1989 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Covington
Colorcon
Chinese Patent Office
McKinsey
Cipla
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot